Adult ADHDParenting ADHD ChildrenADHD TreatmentADHD and Learning DisabilitiesAttention Deficit
PrintEmailDiscussRSS
Home > >

New ADHD Medication Shows Positive Results in Testing

A new drug may help reduce symptoms in ADHD children.

Drug company Addrenex Phamaceuticals reported on September 10 that phase 3 clinical testing for a new ADHD medication, called Clonicel, showed significant positive results.

The medication is a version of clonidine, a widely used hypertension drug that diminishes the body's hyper-reactivity to stress. Clonicel targets the body's stress response center, and may be more effective than stimulants in alleviating mood swings and emotional outbursts associated with ADHD.

This was the first study to test a long-acting version of clonidine in ADHD children. The clinical test, on children ages six to 17, found that symptoms were reduced significantly more than with the placebo.

Addrenex is also currently testing a combination treatment of Clonicel with stimulants, to determine if the two treatments together alleviate a broader range of symptoms than either drug alone.

Learn more about the results of the study and Addrenex Phamaceuticals.

ADDitude DirectoryFind Professionals
Find Schools and Camps
Find Products
Free Newsletter
Free Gift with Sign Up
Adult ADHD
Managing your time, money, career & relationships
Success at School
Keep kids learning! Tips for parents and teachers
Parenting ADD/LD Kids
Strategies for behavior, nutrition, friends & more
 
Copyright © 1998 - 2007 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018